Russell Williams
Well-Known Member
WASHINGTON - An unexpected number of deaths among patients receiving intense therapy to lower their blood sugar forced the National Institutes of Health to abruptly cut short part of a major study on diabetes and heart disease.
The therapy was aimed at reducing to normal levels the blood sugar of type 2 diabetics at especially high risk of heart attack and stroke. There were 257 deaths among people receiving intense diabetes treatment, compared with 203 in the standard treatment group, NIHs National Heart Lung and Blood Institute said.
More than 18 million Americans have diabetes, with type 2 the most common form.
The therapy was aimed at reducing to normal levels the blood sugar of type 2 diabetics at especially high risk of heart attack and stroke. There were 257 deaths among people receiving intense diabetes treatment, compared with 203 in the standard treatment group, NIHs National Heart Lung and Blood Institute said.
More than 18 million Americans have diabetes, with type 2 the most common form.
